awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57168424-D40A3C68-085B-4ACA-A46E-28161FF61D7E
Q57168424-D40A3C68-085B-4ACA-A46E-28161FF61D7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57168424-D40A3C68-085B-4ACA-A46E-28161FF61D7E
Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients
P2860
Q57168424-D40A3C68-085B-4ACA-A46E-28161FF61D7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57168424-D40A3C68-085B-4ACA-A46E-28161FF61D7E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f9310bcda73e8e9996f45c12888db3c4d578b82
P2860
Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States.